1
|
Ben Mihoub A, Elkhoury K, Nel J, Acherar S, Velot E, Malaplate C, Linder M, Latifi S, Kahn C, Huguet M, Yen FT, Arab-Tehrany E. Neuroprotective Effect of Curcumin-Loaded RGD Peptide-PEGylated Nanoliposomes. Pharmaceutics 2023; 15:2665. [PMID: 38140006 PMCID: PMC10747044 DOI: 10.3390/pharmaceutics15122665] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Revised: 11/06/2023] [Accepted: 11/16/2023] [Indexed: 12/24/2023] Open
Abstract
Curcumin is known for its anti-inflammatory, neuroprotective, and antioxidant properties, but its use in biological applications is hindered by its sensitivity to light, oxygen, and temperature. Furthermore, due to its low water solubility, curcumin has a poor pharmacokinetic profile and bioavailability. In this study, we evaluated the potential application of curcumin as a neuroprotective agent encapsulated in RGD peptide-PEGylated nanoliposomes developed from salmon-derived lecithin. Salmon lecithin, rich in polyunsaturated fatty acids, was used to formulate empty or curcumin-loaded nanoliposomes. Transmission electron microscopy, dynamic light scattering, and nanoparticle tracking analysis characterizations indicated that the marine-derived peptide-PEGylated nanoliposomes were spherical in shape, nanometric in size, and with an overall negative charge. Cytotoxicity tests of curcumin-loaded nanoliposomes revealed an improved tolerance of neurons to curcumin as compared to free curcumin. Wild-type SH-SY5Y were treated for 24 h with curcumin-loaded nanoliposomes, followed by 24 h incubation with conditioned media of SH-SY5Y expressing the Swedish mutation of APP containing a high ratio of Aβ40/42 peptides. Our results revealed significantly lower Aβ-induced cell toxicity in cells pre-treated with RGD peptide-PEGylated curcumin-loaded nanoliposomes, as compared to controls. Thus, our data highlight the potential use of salmon lecithin-derived RGD peptide PEGylated nanoliposomes for the efficient drug delivery of curcumin as a neuroprotective agent.
Collapse
Affiliation(s)
- Amina Ben Mihoub
- LIBio Laboratory, University of Lorraine, F-54000 Nancy, France; (A.B.M.); (J.N.); (M.L.); (C.K.)
- LCPM, CNRS, University of Lorraine, F-54000 Nancy, France;
| | - Kamil Elkhoury
- LIBio Laboratory, University of Lorraine, F-54000 Nancy, France; (A.B.M.); (J.N.); (M.L.); (C.K.)
| | - Janske Nel
- LIBio Laboratory, University of Lorraine, F-54000 Nancy, France; (A.B.M.); (J.N.); (M.L.); (C.K.)
| | - Samir Acherar
- LCPM, CNRS, University of Lorraine, F-54000 Nancy, France;
| | - Emilie Velot
- IMoPA, CNRS, University of Lorraine, F-54000 Nancy, France;
| | - Catherine Malaplate
- UR AFPA Laboratory, Qualivie Team, University of Lorraine, F-54000 Nancy, France; (C.M.); (M.H.); (F.T.Y.)
| | - Michel Linder
- LIBio Laboratory, University of Lorraine, F-54000 Nancy, France; (A.B.M.); (J.N.); (M.L.); (C.K.)
| | - Shahrzad Latifi
- Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV 26506, USA;
| | - Cyril Kahn
- LIBio Laboratory, University of Lorraine, F-54000 Nancy, France; (A.B.M.); (J.N.); (M.L.); (C.K.)
| | - Marion Huguet
- UR AFPA Laboratory, Qualivie Team, University of Lorraine, F-54000 Nancy, France; (C.M.); (M.H.); (F.T.Y.)
| | - Frances T. Yen
- UR AFPA Laboratory, Qualivie Team, University of Lorraine, F-54000 Nancy, France; (C.M.); (M.H.); (F.T.Y.)
- INSERM UMR_S 1116 DCAC Laboratory, University of Lorraine, F-54000 Nancy, France
| | - Elmira Arab-Tehrany
- LIBio Laboratory, University of Lorraine, F-54000 Nancy, France; (A.B.M.); (J.N.); (M.L.); (C.K.)
| |
Collapse
|
2
|
Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside. Mol Neurobiol 2022; 59:4384-4404. [PMID: 35545730 DOI: 10.1007/s12035-022-02859-7] [Citation(s) in RCA: 30] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2022] [Accepted: 04/28/2022] [Indexed: 02/07/2023]
Abstract
Alzheimer's disease (AD) is the most common cause of dementia and cognitive impairment; yet, there is currently no treatment. A buildup of Aβ, tau protein phosphorylation, oxidative stress, and inflammation in AD is pathogenic. The accumulation of amyloid-beta (Aβ) peptides in these neurocognitive areas is a significant characteristic of the disease. Therefore, inhibiting Aβ peptide aggregation has been proposed as the critical therapeutic approach for AD treatment. Resveratrol has been demonstrated in multiple studies to have a neuroprotective, anti-inflammatory, and antioxidant characteristic and the ability to minimize Aβ peptides aggregation and toxicity in the hippocampus of Alzheimer's patients, stimulating neurogenesis and inhibiting hippocampal degeneration. Furthermore, resveratrol's antioxidant effect promotes neuronal development by activating the silent information regulator-1 (SIRT1), which can protect against the detrimental effects of oxidative stress. Resveratrol-induced SIRT1 activation is becoming more crucial in developing novel therapeutic options for AD and other diseases that have neurodegenerative characteristics. This review highlighted a better knowledge of resveratrol's mechanism of action and its promising therapeutic efficacy in treating AD. We also highlighted the therapeutic potential of resveratrol as an AD therapeutic agent, which is effective against neurodegenerative disorders.
Collapse
|
3
|
Passeri E, Elkhoury K, Jiménez Garavito MC, Desor F, Huguet M, Soligot-Hognon C, Linder M, Malaplate C, Yen FT, Arab-Tehrany E. Use of Active Salmon-Lecithin Nanoliposomes to Increase Polyunsaturated Fatty Acid Bioavailability in Cortical Neurons and Mice. Int J Mol Sci 2021; 22:11859. [PMID: 34769291 PMCID: PMC8584305 DOI: 10.3390/ijms222111859] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2021] [Revised: 10/19/2021] [Accepted: 10/19/2021] [Indexed: 12/31/2022] Open
Abstract
Omega-3 polyunsaturated fatty acids (n-3 PUFAs) play an important role in the development, maintenance, and function of the brain. Dietary supplementation of n-3 PUFAs in neurological diseases has been a subject of particular interest in preventing cognitive deficits, and particularly in age-related neurodegeneration. Developing strategies for the efficient delivery of these lipids to the brain has presented a challenge in recent years. We recently reported the preparation of n-3 PUFA-rich nanoliposomes (NLs) from salmon lecithin, and demonstrated their neurotrophic effects in rat embryo cortical neurons. The objective of this study was to assess the ability of these NLs to deliver PUFAs in cellulo and in vivo (in mice). NLs were prepared using salmon lecithin rich in n-3 PUFAs (29.13%), and characterized with an average size of 107.90 ± 0.35 nm, a polydispersity index of 0.25 ± 0.01, and a negative particle-surface electrical charge (-50.4 ± 0.2 mV). Incubation of rat embryo cortical neurons with NLs led to a significant increase in docosahexaenoic acid (DHA) (51.5%, p < 0.01), as well as palmitic acid, and a small decrease in oleic acid after 72 h (12.2%, p < 0.05). Twenty mice on a standard diet received oral administration of NLs (12 mg/mouse/day; 5 days per week) for 8 weeks. Fatty acid profiles obtained via gas chromatography revealed significant increases in cortical levels of saturated, monounsaturated, and n-3 (docosahexaenoic acid,) and n-6 (docosapentaenoic acid and arachidonic acid) PUFAs. This was not the case for the hippocampus or in the liver. There were no effects on plasma lipid levels, and daily monitoring confirmed NL biocompatibility. These results demonstrate that NLs can be used for delivery of PUFAs to the brain. This study opens new research possibilities in the development of preventive as well as therapeutic strategies for age-related neurodegeneration.
Collapse
Affiliation(s)
- Elodie Passeri
- LIBio Laboratory, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (E.P.); (K.E.); (M.C.J.G.); (M.L.)
- UR AFPA Laboratory, Qualivie Team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (F.D.); (M.H.); (C.S.-H.); (C.M.)
| | - Kamil Elkhoury
- LIBio Laboratory, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (E.P.); (K.E.); (M.C.J.G.); (M.L.)
| | | | - Frédéric Desor
- UR AFPA Laboratory, Qualivie Team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (F.D.); (M.H.); (C.S.-H.); (C.M.)
| | - Marion Huguet
- UR AFPA Laboratory, Qualivie Team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (F.D.); (M.H.); (C.S.-H.); (C.M.)
| | - Claire Soligot-Hognon
- UR AFPA Laboratory, Qualivie Team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (F.D.); (M.H.); (C.S.-H.); (C.M.)
| | - Michel Linder
- LIBio Laboratory, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (E.P.); (K.E.); (M.C.J.G.); (M.L.)
| | - Catherine Malaplate
- UR AFPA Laboratory, Qualivie Team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (F.D.); (M.H.); (C.S.-H.); (C.M.)
| | - Frances T. Yen
- UR AFPA Laboratory, Qualivie Team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (F.D.); (M.H.); (C.S.-H.); (C.M.)
| | - Elmira Arab-Tehrany
- LIBio Laboratory, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France; (E.P.); (K.E.); (M.C.J.G.); (M.L.)
| |
Collapse
|
4
|
Ben Mihoub A, Acherar S, Frochot C, Malaplate C, Yen FT, Arab-Tehrany E. Synthesis of New Water Soluble β-Cyclodextrin@Curcumin Conjugates and In Vitro Safety Evaluation in Primary Cultures of Rat Cortical Neurons. Int J Mol Sci 2021; 22:ijms22063255. [PMID: 33806807 PMCID: PMC8004725 DOI: 10.3390/ijms22063255] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Revised: 03/18/2021] [Accepted: 03/19/2021] [Indexed: 01/01/2023] Open
Abstract
Self-aggregation of Curcumin (Cur) in aqueous biological environment decreases its bioavailability and in vivo therapeutic efficacy, which hampers its clinical use as candidate for reducing risk of neurodegenerative diseases. Here, we focused on the design of new Cur- β-Cyclodextrin nanoconjugates to improve the solubility and reduce cell toxicity of Cur. In this study, we described the synthesis, structural characterization, photophysical properties and neuron cell toxicity of two new water soluble β-CD/Cur nanoconjugates as new strategy for reducing risks of neurodegenerative diseases. Cur was coupled to one or two β-CD molecules via triazole rings using CuAAC click chemistry strategy to yield β-CD@Cur and (β-CD)2@Cur nanoconjugates, respectively. The synthesized nanoconjugates were found to be able to self-assemble in aqueous condition and form nano-aggregates of an average diameter size of around 35 and 120 nm for β-CD@Cur and (β-CD)2@Cur, respectively. The photophysical properties, water solubility and cell toxicity on rat embryonic cortical neurons of the designed nanoconjugates were investigated and compared to that of Cur alone. The findings revealed that both new nanoconjugates displayed better water solubility and in vitro biocompatibility than Cur alone, thus making it possible to envisage their use as future nano-systems for the prevention or risk reduction of neurodegenerative diseases.
Collapse
Affiliation(s)
- Amina Ben Mihoub
- LIBio Laboratory, Université de Lorraine, F-54000 Nancy, France
- LCPM, CNRS, Université de Lorraine, F-54000 Nancy, France
- LRGP, CNRS, Université de Lorraine, F-54000 Nancy, France;
- Correspondence: (A.B.M.); (S.A.); (E.A.-T.)
| | - Samir Acherar
- LCPM, CNRS, Université de Lorraine, F-54000 Nancy, France
- Correspondence: (A.B.M.); (S.A.); (E.A.-T.)
| | - Céline Frochot
- LRGP, CNRS, Université de Lorraine, F-54000 Nancy, France;
| | - Catherine Malaplate
- URAFPA, INRAE, Université de Lorraine, F-54000 Nancy, France; (C.M.); (F.T.Y.)
| | - Frances T. Yen
- URAFPA, INRAE, Université de Lorraine, F-54000 Nancy, France; (C.M.); (F.T.Y.)
| | - Elmira Arab-Tehrany
- LIBio Laboratory, Université de Lorraine, F-54000 Nancy, France
- Correspondence: (A.B.M.); (S.A.); (E.A.-T.)
| |
Collapse
|
5
|
Sousa JCE, Santana ACF, MagalhÃes GJP. Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential. ARQUIVOS DE NEURO-PSIQUIATRIA 2020; 78:501-511. [PMID: 32520230 DOI: 10.1590/0004-282x20200010] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2019] [Accepted: 01/17/2020] [Indexed: 12/21/2022]
Abstract
BACKGROUND Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive and irreversible loss of cognitive function. The presence of senile plaques is one of the pathological markers of the disease and is associated with the onset of neuroinflammatory mechanisms. The exact pathophysiology of AD has not been completely understood, and there are no curative therapies yet. Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a polyphenol that is noted for its antioxidant and anti-inflammatory properties. OBJECTIVE To review the role of resveratrol in the pathophysiological aspects of AD. METHODS This study carried out a literature review using PubMed/Medline, Virtual Health Library (VHL), Web of Sciences, SCOPUS and the Cochrane Library databases. Original research articles, describing both in vitro and in vivo experiments, published between 2008 and 2018, were included. RESULTS We identified 667 articles, of which 619 were excluded because they were repeated or did not follow the inclusion criteria. The present study includes the remaining 48 articles. DISCUSSION Resveratrol demonstrates beneficial and protective effects in AD models and seems to provide a promising therapeutic alternative. CONCLUSION Although resveratrol appears to mitigate some pathophysiological aspects of AD, further studies are needed to prove the safety and efficacy of this compound in humans.
Collapse
Affiliation(s)
- Júlia Canto E Sousa
- Universidade Salvador, Escola de Ciências da Saúde, Departamento de Nutrição, Salvador BA, Brazil
| | | | | |
Collapse
|
6
|
Malaplate C, Poerio A, Huguet M, Soligot C, Passeri E, Kahn CJF, Linder M, Arab-Tehrany E, Yen FT. Neurotrophic Effect of Fish-Lecithin Based Nanoliposomes on Cortical Neurons. Mar Drugs 2019; 17:md17070406. [PMID: 31323972 PMCID: PMC6669490 DOI: 10.3390/md17070406] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2019] [Revised: 06/29/2019] [Accepted: 07/01/2019] [Indexed: 12/13/2022] Open
Abstract
Lipids play multiple roles in preserving neuronal function and synaptic plasticity, and polyunsaturated fatty acids (PUFAs) have been of particular interest in optimizing synaptic membrane organization and function. We developed a green-based methodology to prepare nanoliposomes (NL) from lecithin that was extracted from fish head by-products. These NL range between 100–120 nm in diameter, with an n-3/n-6 fatty acid ratio of 8.88. The high content of n-3 PUFA (46.3% of total fatty acid content) and docosahexanoic acid (26%) in these NL represented a means for enrichment of neuronal membranes that are potentially beneficial for neuronal growth and synaptogenesis. To test this, the primary cultures of rat embryo cortical neurons were incubated with NL on day 3 post-culture for 24 h, followed by immunoblots or immunofluorescence to evaluate the NL effects on synaptogenesis, axonal growth, and dendrite formation. The results revealed that NL-treated cells displayed a level of neurite outgrowth and arborization on day 4 that was similar to those of untreated cells on day 5 and 6, suggesting accelerated synapse formation and neuronal development in the presence of NL. We propose that fish-derived NL, by virtue of their n-3 PUFA profile and neurotrophic effects, represent a new innovative bioactive vector for developing preventive or curative treatments for neurodegenerative diseases.
Collapse
Affiliation(s)
- Catherine Malaplate
- Research Unit Animal and Functionality of Animal Products, Quality of Diet and Aging Team (UR AFPA) Laboratory, Qualivie team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France
| | - Aurelia Poerio
- Research Unit Animal and Functionality of Animal Products, Quality of Diet and Aging Team (UR AFPA) Laboratory, Qualivie team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France
- LIBio Laboratory, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France
| | - Marion Huguet
- Research Unit Animal and Functionality of Animal Products, Quality of Diet and Aging Team (UR AFPA) Laboratory, Qualivie team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France
| | - Claire Soligot
- Research Unit Animal and Functionality of Animal Products, Quality of Diet and Aging Team (UR AFPA) Laboratory, Qualivie team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France
| | - Elodie Passeri
- Research Unit Animal and Functionality of Animal Products, Quality of Diet and Aging Team (UR AFPA) Laboratory, Qualivie team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France
- LIBio Laboratory, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France
| | - Cyril J F Kahn
- LIBio Laboratory, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France
| | - Michel Linder
- LIBio Laboratory, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France
| | - Elmira Arab-Tehrany
- LIBio Laboratory, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France.
| | - Frances T Yen
- Research Unit Animal and Functionality of Animal Products, Quality of Diet and Aging Team (UR AFPA) Laboratory, Qualivie team, University of Lorraine, 54505 Vandoeuvre-lès-Nancy, France.
| |
Collapse
|
7
|
Hu L, Zhang R, Yuan Q, Gao Y, Yang MQ, Zhang C, Huang J, Sun Y, Yang W, Yang JY, Min ZL, Cheng J, Deng Y, Hu X. The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell. BMC SYSTEMS BIOLOGY 2018; 12:119. [PMID: 30547775 PMCID: PMC6293494 DOI: 10.1186/s12918-018-0633-3] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Background Accumulation of amyloid β-peptide (Aβ) is implicated in the pathogenesis and development of Alzheimer’s disease (AD). Neuron-enriched miRNA was aberrantly regulated and may be associated with the pathogenesis of AD. However, regarding whether miRNA is involved in the accumulation of Aβ in AD, the underlying molecule mechanism remains unclear. Therefore, we conduct a systematic identification of the promising role of miRNAs in Aβ deposition, and shed light on the molecular mechanism of target miRNAs underlying SH-SY5Y cells treated with Aβ-induced cytotoxicity. Results Statistical analyses of microarray data revealed that 155 significantly upregulated and 50 significantly downregulated miRNAs were found on the basis of log2 | Fold Change | ≥ 0.585 and P < 0.05 filter condition through 2588 kinds of mature miRNA probe examined. PCR results show that the expression change trend of the selected six miRNAs (miR-6845-3p, miR-4487, miR-4534, miR-3622-3p, miR-1233-3p, miR-6760-5p) was consistent with the results of the gene chip. Notably, Aβ25–35 downregulated hsa-miR-4487 and upregulated hsa-miR-6845-3p in SH-SY5Y cell lines associated with Aβ-mediated pathophysiology. Increase of hsa-miR-4487 could inhibit cells apoptosis, and diminution of hsa-miR-6845-3p could attenuate axon damage mediated by Aβ25–35 in SH-SY5Y. Conclusions Together, these findings suggest that dysregulation of hsa-miR-4487 and hsa-miR-6845-3p contributed to the pathogenesis of AD associated with Aβ25–35 mediated by triggering cell apoptosis and synaptic dysfunction. It might be beneficial to understand the pathogenesis and development of clinical diagnosis and treatment of AD. Further, our well-designed validation studies will test the miRNAs signature as a prognostication tool associated with clinical outcomes in AD.
Collapse
Affiliation(s)
- Ling Hu
- Department of Anesthesiology, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, 430064, China.,Department of Pharmacy, College of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, Hubei Province, China
| | - Rong Zhang
- Department of Pharmacy, College of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, Hubei Province, China
| | - Qiong Yuan
- Department of Pharmacy, College of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, Hubei Province, China
| | - Yinping Gao
- Department of Pharmacy, Shanghai University of Medicine & Health Sciences, Shanghai, 201318, China
| | - Mary Q Yang
- MidSouth Bioinformatics Center, Department of Information Science, George Washington Donaghey College of Engineering and Information Technology and Joint Bioinformatics Graduate Program, University of Arkansas at Little Rock and University of Arkansas for Medical Sciences, Little Rock, AR, 72204, USA
| | - Chunxiang Zhang
- Department of Pharmacy, College of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, Hubei Province, China.,Department of Biomedical Engineering, School of Medicine and School of Engineering, The University of Alabama, Birmingham, 35201, USA
| | - Jiankun Huang
- Department of Pharmacy, Shanghai University of Medicine & Health Sciences, Shanghai, 201318, China
| | - Yufei Sun
- Department of Pharmacy, Shanghai University of Medicine & Health Sciences, Shanghai, 201318, China
| | - William Yang
- MidSouth Bioinformatics Center, Department of Information Science, George Washington Donaghey College of Engineering and Information Technology and Joint Bioinformatics Graduate Program, University of Arkansas at Little Rock and University of Arkansas for Medical Sciences, Little Rock, AR, 72204, USA
| | - Jack Y Yang
- MidSouth Bioinformatics Center, Department of Information Science, George Washington Donaghey College of Engineering and Information Technology and Joint Bioinformatics Graduate Program, University of Arkansas at Little Rock and University of Arkansas for Medical Sciences, Little Rock, AR, 72204, USA
| | - Zhen-Li Min
- Department of Pharmacy, College of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, Hubei Province, China
| | - Jing Cheng
- Department of Pharmacy, College of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, Hubei Province, China
| | - Youping Deng
- Bioinformatics Core, Department of Complementary & Integrative Medicine, University of Hawaii John A. Burns School of Medicine, Honolulu, HI, 96813, USA.
| | - Xiamin Hu
- Department of Pharmacy, Shanghai University of Medicine & Health Sciences, Shanghai, 201318, China.
| |
Collapse
|